# Treg cells retain stable lineage commitment during pregnancy in mice after late gestation inflammatory challenge

**Authors:** Kerrie L Foyle, Ella S Green, Jessie R Walker‐Rogers, Ha M Tran, David M Olson, Lachlan M Moldenhauer, Sarah A Robertson

PMC · DOI: 10.1111/imcb.70081 · Immunology and Cell Biology · 2026-02-24

## TL;DR

This study shows that Treg cells in pregnant mice maintain their identity even when inflammation is induced, which could help understand preterm birth.

## Contribution

The study reveals that Treg cells retain lineage stability during pregnancy despite inflammatory challenges.

## Key findings

- Ex-Foxp3 cells were found in uterine-draining lymph nodes but did not increase with inflammation.
- Treg cells retained their lineage program and did not adopt proinflammatory phenotypes during late gestation.
- RNA sequencing showed loss of Treg lineage markers in ex-Foxp3 cells but no expansion due to inflammation.

## Abstract

Inflammation is a major driver of preterm birth, a common pregnancy disorder and the leading cause of childhood death. T regulatory (Treg) cells are essential mediators of maternal fetal tolerance and are critical for constraining uterine inflammation. In some tissue settings, loss of Foxp3 expression can cause instability in Treg cell lineage commitment, elevated production of proinflammatory cytokines and compromised suppressive function. Whether preterm birth susceptibility is associated with loss of lineage fidelity and adoption of proinflammatory phenotypes in Treg cells is unknown. In this study, we investigated the lineage stability of Treg cells in vivo in pregnant mice using a Foxp3 fate‐mapping system and models of preterm birth induced by late‐gestation inflammatory challenge with lipopolysaccharide (LPS) or interleukin‐1β (IL‐1β). Ex‐Foxp3‐expressing (ex‐Foxp3) cells were observed in the uterus‐draining lymph nodes (udLNs) in non‐pregnant mice and in similar abundance across normal gestation, and a proportion expressed proinflammatory cytokines IFNγ and/or IL‐17A. Bulk RNA‐sequencing of sorted Treg and ex‐Foxp3 cells from late‐gestation udLNs revealed substantial loss of the Treg cell lineage program in ex‐Foxp3 cells, characterized by reversal in expression of canonical Treg cell genes and pathways. Late gestation LPS or IL‐1β administration to induce preterm birth did not expand the ex‐Foxp3 cell population in the uDLNs or uterine decidua. We conclude that uterine Treg cells exhibit a high level of lineage stability in pregnancy regardless of proinflammatory challenge. Whether there is any biological or pathophysiological significance of ex‐Foxp3 cells in gestational tissues remains to be defined.

In this study, we used Foxp3‐fatemapping mice to examine the cell lineage stability of Treg cells in pregnancy. Ex‐Foxp3 cells were identified in gestational tissues. However, Treg cells retained lineage stability with no increased ex‐Foxp3 generation, regardless of inflammatory challenges that induce preterm birth.

## Linked entities

- **Genes:** FOXP3 (forkhead box P3) [NCBI Gene 50943]
- **Proteins:** IL1B (interleukin 1 beta), IRF6 (interferon regulatory factor 6), IFNG (interferon gamma), IL17A (interleukin 17A)
- **Species:** Mus musculus (taxon 10090)

## Full-text entities

- **Genes:** Tgfb1 (transforming growth factor, beta 1) [NCBI Gene 21803] {aka TGF-beta1, TGFbeta1, Tgfb, Tgfb-1}, Gzmk (granzyme K) [NCBI Gene 14945], TNFRSF18 (TNF receptor superfamily member 18) [NCBI Gene 8784] {aka AITR, CD357, ENERGEN, GITR, GITR-D}, IL6 (interleukin 6) [NCBI Gene 3569] {aka BSF-2, BSF2, CDF, HGF, HSF, IFN-beta-2}, MMP9 (matrix metallopeptidase 9) [NCBI Gene 4318] {aka CLG4B, GELB, MANDP2, MMP-9}, Ccr8 (C-C motif chemokine receptor 8) [NCBI Gene 12776] {aka C-C, C-C CKR-8, CC-CKR-8, CCR-8, CKR-8, Cmkbr8}, Tcf7 (transcription factor 7, T cell specific) [NCBI Gene 21414] {aka TCF-1, Tcf1}, Stat6 (signal transducer and activator of transcription 6) [NCBI Gene 20852], Nfkb1 (nuclear factor of kappa light polypeptide gene enhancer in B cells 1, p105) [NCBI Gene 18033] {aka NF-KB1, NF-kappaB, NF-kappaB1, p105, p50, p50/p105}, Cxcr6 (C-X-C motif chemokine receptor 6) [NCBI Gene 80901] {aka BONZO, STRL33}, Il17a (interleukin 17A) [NCBI Gene 16171] {aka Ctla-8, Ctla8, IL-17, IL-17A, Il17}, ZEB2 (zinc finger E-box binding homeobox 2) [NCBI Gene 9839] {aka HSPC082, SIP-1, SIP1, SMADIP1, ZFHX1B}, Cd40lg (CD40 ligand) [NCBI Gene 21947] {aka CD154, CD40-L, Cd40l, HIGM1, IGM, IMD3}, CTLA4 (cytotoxic T-lymphocyte associated protein 4) [NCBI Gene 1493] {aka ALPS5, CD, CD152, CELIAC3, CTLA-4, GRD4}, TCF7 (transcription factor 7) [NCBI Gene 6932] {aka TCF-1}, Trav6-3 (T cell receptor alpha variable 6-3) [NCBI Gene 328483] {aka Gm13948, Gm193, Gm4, TCR}, Gata1 (GATA binding protein 1) [NCBI Gene 14460] {aka Gata-1, Gf-1, eryf1}, Tcf4 (transcription factor 4) [NCBI Gene 21413] {aka 5730422P05Rik, ASP-I2, E2-2, E2.2, ITF-2, ITF-2b}, Il1b (interleukin 1 beta) [NCBI Gene 16176] {aka IL-1beta, Il-1b}, TNF (tumor necrosis factor) [NCBI Gene 7124] {aka DIF, IMD127, TNF-alpha, TNFA, TNFSF2, TNLG1F}, Ebi3 (Epstein-Barr virus induced gene 3) [NCBI Gene 50498] {aka EBI-3, IL-27}, Irf1 (interferon regulatory factor 1) [NCBI Gene 16362] {aka Irf-1}, Tcf7l2 (transcription factor 7 like 2, T cell specific, HMG box) [NCBI Gene 21416] {aka TCF4B, TCF4E, Tcf-4, Tcf4}, Tlr4 (toll-like receptor 4) [NCBI Gene 21898] {aka Lps, Ly87, Ran/M1, Rasl2-8}, ALB (albumin) [NCBI Gene 213] {aka FDAHT, HSA, PRO0883, PRO0903, PRO1341}, Gzmb (granzyme B) [NCBI Gene 14939] {aka CCP-1/C11, CCP1, Ctla-1, Ctla1, GZB}, ID2 (inhibitor of DNA binding 2) [NCBI Gene 3398] {aka GIG8, ID2A, ID2H, bHLHb26}, Cxcr5 (C-X-C motif chemokine receptor 5) [NCBI Gene 12145] {aka Blr1, CXC-R5, CXCR-5, Gpcr6, MDR15}, Tnfrsf9 (tumor necrosis factor receptor superfamily, member 9) [NCBI Gene 21942] {aka 4-1BB, A930040I11Rik, CDw137, Cd137, ILA, Ly63}, RAG1 (recombination activating 1) [NCBI Gene 5896] {aka RAG-1, RNF74}, Xcr1 (chemokine (C motif) receptor 1) [NCBI Gene 23832] {aka Ccxcr1, Gpr5, mXcr1}, Ccr6 (C-C motif chemokine receptor 6) [NCBI Gene 12458] {aka CC-CKR-6, CCR-6, Cmkbr6, KY411}, Satb1 (special AT-rich sequence binding protein 1) [NCBI Gene 20230] {aka 2610306G12Rik}, IL1B (interleukin 1 beta) [NCBI Gene 3553] {aka IL-1, IL1-BETA, IL1F2, IL1beta}, Il4 (interleukin 4) [NCBI Gene 16189] {aka BSF-1, Il-4}, Fcr (Fc receptor) [NCBI Gene 109615], Il10 (interleukin 10) [NCBI Gene 16153] {aka CSIF, If2a, Il-10}, Rflnb (refilin B) [NCBI Gene 76566] {aka 1500005K14Rik, Fam101b, RefilinB, cfm}, Ikzf2 (IKAROS family zinc finger 2) [NCBI Gene 22779] {aka A730095J18Rik, Helios, Zfpn1a2, Znfn1a2}, Tnfrsf4 (tumor necrosis factor receptor superfamily, member 4) [NCBI Gene 22163] {aka ACT35, CD134, Ly-70, Ox40, TXGP1L, Txgp1}, Irf4 (interferon regulatory factor 4) [NCBI Gene 16364] {aka IRF-4, LSIRF, NF-EM5, Spip}, Tox2 (TOX high mobility group box family member 2) [NCBI Gene 269389] {aka Gcx1, RxHMG1}, Gzmc (granzyme C) [NCBI Gene 14940] {aka B10, CCP2, Ctla-5, Ctla5}, Foxp3 (forkhead box P3) [NCBI Gene 20371] {aka JM2, scurfin, sf}, Cish (cytokine inducible SH2-containing protein) [NCBI Gene 12700] {aka CIS-1, CIS1, Cis, F17, F23, SOCS}, FOXP3 (forkhead box P3) [NCBI Gene 50943] {aka AIID, DIETER, IPEX, JM2, PIDX, XPID}, Ptprc (protein tyrosine phosphatase receptor type C) [NCBI Gene 19264] {aka B220, CD45R, Cd45, L-CA, Ly-5, Lyt-4}, Il21 (interleukin 21) [NCBI Gene 60505] {aka IL-21}, Socs2 (suppressor of cytokine signaling 2) [NCBI Gene 216233] {aka 8030460M17, CIS2, Cish2, D130043N08Rik, JAB, SOCS-2}, Ifng (interferon gamma) [NCBI Gene 15978] {aka IFN-g, If2f, Ifg}, Il2ra (interleukin 2 receptor, alpha chain) [NCBI Gene 16184] {aka CD25, Il2r, Ly-43}, Tnfrsf1a (tumor necrosis factor receptor superfamily, member 1a) [NCBI Gene 21937] {aka CD120a, FPF, TNF-R, TNF-R-I, TNF-R1, TNF-R55}, Sema4a (sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4A) [NCBI Gene 20351] {aka SemB, Semab}, EOS (eosinophilia, familial) [NCBI Gene 7908], Themis (thymocyte selection associated) [NCBI Gene 210757] {aka E430004N04Rik, Gasp, Spot, Tsepa, thylex}, Tbx21 (T-box 21) [NCBI Gene 57765] {aka TBT1, Tbet, Tblym}, Il2 (interleukin 2) [NCBI Gene 16183] {aka Il-2}, Lrrc32 (leucine rich repeat containing 32) [NCBI Gene 434215] {aka D11S833Eh, D7H11S833E, EG434215, Garp}, Lef1 (lymphoid enhancer binding factor 1) [NCBI Gene 16842] {aka 3000002B05, Lef-1}, Ccr3 (C-C motif chemokine receptor 3) [NCBI Gene 12771] {aka CC-CKR3, CKR3, Cmkbr1l2, Cmkbr3}
- **Diseases:** inflammation (MESH:D007249), inflammatory arthritis (MESH:D001168), term labor (MESH:D000088562), death (MESH:D003643), infection (MESH:D007239), implantation failure (MESH:D051437), preterm birth (MESH:D047928), infertility (MESH:D007246), P4 insufficiency (MESH:D000309), lung (MESH:D008171), preeclampsia (MESH:D011225), NOD (MESH:D020191), chorioamniotic membrane (MESH:D015433), proinflammatory cytokines (MESH:D000080424), Inflammatory bowel disease (MESH:D015212), hemorrhagic (MESH:D006470), miscarriage (MESH:D000022), autoimmune disease (MESH:D001327), liver (MESH:D017093), Type I diabetes (MESH:D003922), dislocation (MESH:D004204), premature labor (MESH:D007752), pregnancy disorder (MESH:D011254)
- **Chemicals:** KHCO3 (MESH:C026329), BV421 (-), methanol (MESH:D000432), Trypan Blue (MESH:D014343), salt (MESH:D012492), penicillin (MESH:D010406), ionomycin (MESH:D015759), 2.2.2-tribromoethanol (MESH:C062527), PMA (MESH:D013755), NH4Cl (MESH:D000643), EDTA (MESH:D004492), streptomycin (MESH:D013307), water (MESH:D014867), L-glutamine (MESH:D005973), NaN3 (MESH:D019810), CO2 (MESH:D002245), LPS (MESH:D008070), PBS (MESH:D007854), P4 (MESH:C015586), Progesterone (MESH:D011374), formaldehyde (MESH:D005557)
- **Species:** Escherichia coli (E. coli, species) [taxon 562], Mus musculus (house mouse, species) [taxon 10090], Homo sapiens (human, species) [taxon 9606]
- **Cell lines:** c — Mus musculus (Mouse), Hepatocellular carcinoma of the mouse, Cancer cell line (CVCL_9103)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12972239/full.md

## Figures

6 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12972239/full.md

## References

102 references — full list in the complete paper: https://tomesphere.com/paper/PMC12972239/full.md

---
Source: https://tomesphere.com/paper/PMC12972239